Geistlich Pharma, North America, Inc.
$401.7K 2,543 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Agfa HealthCare Corporation
Agfa HealthCare Corporation reported $400,893.12 across General Payments, Research, and Ownership to 49 physicians and teaching hospitals across 49 transactions.
- $400.9K
- All-tracks total
- 49
- Transactions
- 49
- Recipients
- +$163.9K
- General Payments vs PY2023
Agfa HealthCare Corporation reported $400,893.12 across all CMS Open Payments tracks (General + Research + Ownership) to 49 physicians and teaching hospitals in Program Year 2024 - ranking #822 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $400,893.12, averaging $8.2K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer agfa-healthcare-corporation Agfa HealthCare Corporation
$400.9K · #822/1,925 · 0.0% industry · PY2024
- TOT $400.9K
- RANK #822
- SHARE 0.0%
- TXN 49
- RCP 49
- CAT 3
- GEN $400.9K
- ΔGEN +$163.9K
- TOP1 39.0%
- PY 2024
Volume peers
Nearest volume peer: Geistlich Pharma, North America, Inc. ($401.7K)
Agfa HealthCare Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Agfa HealthCare Corporation's CMS-reported General Payments increased by $163.9K (+69.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AGFA HEALTHCARE CORPORATIONPY2023: AGFA HEALTHCARE CORPORATIONPY2024: Agfa HealthCare Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $237,031.05
- PY2024
- $400,893.12
What the Data Shows for Agfa HealthCare Corporation
Agfa HealthCare Corporation ranks #822 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $400,893.12 across 49 transactions to 49 physicians and teaching hospitals - $8.2K per transaction and $8.2K per recipient on average.
"Gift" leads the 3-category general-payment breakdown below at $295.7K (73.8% of General Payments, 23 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 3 types of general payments, Agfa HealthCare Corporation's largest category was "Gift" at $295.7K - 73.8% of General Payments.
How Agfa HealthCare Corporation divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Gift | $295.7K | 23 | 73.8% |
| Charitable Contribution | $103.3K | 9 | 25.8% |
| Food and Beverage | $1.9K | 17 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $359,168.00 (89.6%) of $400,893.12 in this company's General Payments records across 35 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Agfa HealthCare Corporation
The five named recipients with the highest reported General Payments from this company
- 1
University Health System
$156,288.50 across 5 reported transactions
- 2
Ronald Reagan Ucla
$101,442.00 across 2 reported transactions
- 3
Adventhealth Orlando
$65,000.00 across 1 reported transactions
- 4
Umass Memorial Medical Center
$20,405.00 across 2 reported transactions
- 5
Santa Clara Valley Medical Center
$16,032.50 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Agfa HealthCare Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Agfa HealthCare Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Agfa HealthCare Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Osseus Fusion Systems, LLC
$399.7K 120 recipients
Compare payment profiles
Onkos Surgical, Inc.
$402.3K 461 recipients
Compare payment profiles
Mizuho America, Inc.
$403.0K 57 recipients
Compare payment profiles
Dentsply LLC
$397.9K 434 recipients
Compare payment profiles
Nova Eye, Inc.
$404.7K 474 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.